Literature DB >> 21489978

Circulating CD56+ cells of diabetic women show deviated homing potential for specific tissues during and following pregnancy.

A V C Seaward1, S D Burke, H Ramshaw, G N Smith, B A Croy.   

Abstract

BACKGROUND: Human uterine natural killer (uNK) cells, the dominant lymphocytes in early pregnancy decidua, are important for spiral arterial remodelling. uNK cells are thought to arise from circulating CD56(bright) NK cells that egress into decidualizing endometrium. Both incomplete spiral arterial modification and aberrant NK cell function have been linked with pre-eclampsia, a syndrome that is more prevalent in diabetic women. Since previous in vitro studies have shown that changes in decidual endothelium induced by type 1 diabetes (T1D) reduce its interactions with circulating leucocytes, we hypothesized that diabetes additionally has direct effects on circulating CD56(+) NK cells that impair their decidual homing potential.
METHODS: Serial blood samples were collected from control, T1D and T2D pregnant women throughout and after pregnancy. In vitro adhesion under shear forces was used to assay the functional capacity of circulating leucocytes and of CD56(+) cells to adhere to endothelium in cryostat sections of gestation day (gd) 7 normal mouse decidua, pancreas and lymph node.
RESULTS: Fewer CD56(+) cells from diabetic compared with control women adhered to normal decidual endothelium. The CD56(+) cell/total cell adhesion ratio was also lower in diabetics. More diabetic CD56(+) cells adhered to pancreatic endothelium and their proportion was greater than for controls. Neither absolute nor proportional adhesion of CD56(+) cells to lymph node endothelium differed between diabetics and controls.
CONCLUSIONS: The CD56(+) cell adhesion patterns of T1D and T2D women differ from those of non-diabetic women and support the hypothesis that diabetes impairs mechanisms that could be used by CD56(+) cells for egress into decidua.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21489978      PMCID: PMC3260321          DOI: 10.1093/humrep/der114

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  51 in total

1.  Endometrial vascularity by three-dimensional power Doppler ultrasound and cytokines: a complementary approach to assess uterine receptivity.

Authors:  Nathalie Lédée; Gérard Chaouat; Valérie Serazin; Raoul Lombroso; Sylvie Dubanchet; Pierre Oger; Nabil Louafi; Yves Ville
Journal:  J Reprod Immunol       Date:  2007-10-24       Impact factor: 4.054

2.  Evidence for immune cell involvement in decidual spiral arteriole remodeling in early human pregnancy.

Authors:  Samantha D Smith; Caroline E Dunk; John D Aplin; Lynda K Harris; Rebecca L Jones
Journal:  Am J Pathol       Date:  2009-04-06       Impact factor: 4.307

3.  Endometrial NK cells are special immature cells that await pregnancy.

Authors:  Irit Manaster; Saar Mizrahi; Debra Goldman-Wohl; Hen Y Sela; Noam Stern-Ginossar; Dikla Lankry; Raizy Gruda; Arye Hurwitz; Yuval Bdolah; Ronit Haimov-Kochman; Simcha Yagel; Ofer Mandelboim
Journal:  J Immunol       Date:  2008-08-01       Impact factor: 5.422

4.  Uterine natural killer cells and angiogenesis in recurrent reproductive failure.

Authors:  Siobhan Quenby; Helena Nik; Barbara Innes; Gendie Lash; Mark Turner; Jo Drury; Judith Bulmer
Journal:  Hum Reprod       Date:  2008-10-03       Impact factor: 6.918

Review 5.  Natural killer cell-triggered vascular transformation: maternal care before birth?

Authors:  Jianhong Zhang; Zhilin Chen; Graeme N Smith; B Anne Croy
Journal:  Cell Mol Immunol       Date:  2010-08-16       Impact factor: 11.530

6.  DBA-lectin reactivity defines natural killer cells that have homed to mouse decidua.

Authors:  J H Zhang; A T Yamada; B A Croy
Journal:  Placenta       Date:  2009-09-17       Impact factor: 3.481

7.  CD56bright cells increase expression of {alpha}4 integrin at ovulation in fertile cycles.

Authors:  Crystal G Peralta; Victor K Han; Julie Horrocks; B Anne Croy; Marianne J van den Heuvel
Journal:  J Leukoc Biol       Date:  2008-07-15       Impact factor: 4.962

8.  NK cells detect changes in adaptive immunity within mouse decidua from gestation day eight.

Authors:  K Hatta; M J van den Heuvel; B A Croy
Journal:  Placenta       Date:  2009-05-09       Impact factor: 3.481

Review 9.  Accumulation of uterine CD16(-) natural killer (NK) cells: friends, foes, or Jekyll-and-Hyde relationship for the conceptus?

Authors:  Kotaro Kitaya
Journal:  Immunol Invest       Date:  2008       Impact factor: 3.657

Review 10.  The ins and outs of leukocyte integrin signaling.

Authors:  Clare L Abram; Clifford A Lowell
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

View more
  5 in total

Review 1.  Future directions of clinical laboratory evaluation of pregnancy.

Authors:  Kenneth D Beaman; Mukesh K Jaiswal; Svetlana Dambaeva; Alice Gilman-Sachs
Journal:  Cell Mol Immunol       Date:  2014-07-21       Impact factor: 11.530

2.  Maternal obesity drives functional alterations in uterine NK cells.

Authors:  Sofie Perdu; Barbara Castellana; Yoona Kim; Kathy Chan; Lauren DeLuca; Alexander G Beristain
Journal:  JCI Insight       Date:  2016-07-21

Review 3.  Group B streptococcal infection of the genitourinary tract in pregnant and non-pregnant patients with diabetes mellitus: An immunocompromised host or something more?

Authors:  Lynsa M Nguyen; Joel I Omage; Kristen Noble; Kelsey L McNew; Daniel J Moore; David M Aronoff; Ryan S Doster
Journal:  Am J Reprod Immunol       Date:  2021-10-19       Impact factor: 3.886

4.  Homing receptor expression is deviated on CD56+ blood lymphocytes during pregnancy in Type 1 diabetic women.

Authors:  Suzanne D Burke; Alexandra V C Seaward; Heather Ramshaw; Graeme N Smith; Sophia Virani; Barbara A Croy; Patricia D A Lima
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

Review 5.  The Immunogenetic Conundrum of Preeclampsia.

Authors:  A Inkeri Lokki; Jenni K Heikkinen-Eloranta; Hannele Laivuori
Journal:  Front Immunol       Date:  2018-11-13       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.